Last week’s Emmys saw top grateful winners pour into their agents, directors, and fans, but there was one notable recipient of several stars who didn’t get much thanks: the injectable drug semaglutide, its brand name Ozempic.
The drug is an insulin regulator for pre-diabetes, made by the Danish pharmaceutical giant Novo Nordisk, whose main side effect is significant weight loss. It’s saturated the industry in recent months, helping the beautiful and the wealthy shed extra pounds in the never-ending Los Angeles hobby of improving looks. Hollywood nutritionist Matt Mawald says: diverse The main benefits of the injections are to “reduce and withdraw insulin secretion, slowing your stomach from emptying it. Promotes satiety from food.”
A senior power broker said diverse Half of her contact paper last week was filled with friends and clients willing to discuss the risks of Ozempic, which claimed to have followers from every corner of the industry. Moguls, reality stars, veteran film producers, and, of course, actors quietly sing the praises of medicine on Signal, the encrypted messaging app mostly used for secret chats. Celebrity hairstyling, makeup and styling teams are now accepting injections as part of their hair care rituals before major events. Within months, it became worse in Hollywood — especially given that its most ardent users are neither diabetic nor needing the drug. It is currently provided by doctors and nutritionists, despite rumors that you can also register the drug at medical spas in Arizona. Of course, not cheap.
“It would easily be $1,200 to $1,500 a month. If you go out and buy an Ozempic pen from a drugstore, that’s the price you’re going to pay,” Mawald adds.
However, the frantic response from industry types has caused problems for the major insurers.
“It’s becoming a big problem, everyone is jumping on this bandwagon. Insurance companies are refusing to cover this for anyone who doesn’t have diabetes. It has led to panic. Pharmacies have units that are late to order until December,” adds Mawald.
Even more worrying, according to several reports, is that the massive demand leaves those who need the injections struggling with a low supply. A second version of semaglutide called Wegovy, which specifically targets obesity, is also widespread and appears to be rarely available.
The drug grabbed international headlines three months ago after it went viral on TikTok, where the trend #MyOzempicJourney showed eye-catching transformations (The Guardian reported that the hashtag #Ozempic had been viewed 74 million times on the platform). Earlier this month, Town and Country wrote a letter claiming that the drug was the talk of coastal dinner parties. Glamor magazine followed suit.
“Obesity is an epidemic,” warned Dr. Zhaoping Li, chief of clinical nutrition at UCLA’s David Geffen School of Medicine. “The problem is that this is one of the tools in our box, it is not the end of everything. The longest study of these injections was done over less than two years. Not many questions were answered.”
Dr. Lee added that the maximum weight loss seen in most patients is 15% of body mass, which brings us back to the horrific fact that Hollywood geeks hate to hear: “It’s all about lifestyle. Being active, eating right, and managing stress. “.
Like any miracle drug for weight loss, there are doubts about its long-term use. In addition to the smaller form, a notable side effect is “digestive phenomena–bloating, constipation, and diarrhea,” according to Town and Country.
When asked about this unpleasant danger, a talent publicist said frankly, “Who cares? Everyone who works in this business has IBS, anyway.”